Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03214510 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thoracic Epidural Analgesia or Four-Quadrant Transversus Abdominus Plane Block in Reducing Pain in Patients Undergoing Liver Surgery

StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Jul 31, 2026 to Jul 31, 2027v22
  2. Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 96 to confirmed 101
    • Site details revised
    v21
  3. 5 versions Re-verified since Aug 16, 2023, no change to tracked fieldsv16-v20
  4. Primary completion date: Aug 31, 2023 to Jul 31, 2026
    • Study completion date: Aug 31, 2024 to Jul 31, 2026
    v15
  5. Primary completion date: Aug 31, 2022 to Aug 31, 2023
    • Study completion date: Aug 31, 2023 to Aug 31, 2024
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Study description revised
    • Site contact updated
    v13
  2. Site contact updatedv12
  3. Re-verified, no change to tracked fieldsv11
  4. Primary endpoint revisedv10 Show 9 more changesShow less
    • Primary completion date: Oct 2022 to Aug 31, 2022
    • Study completion date: Oct 2023 to Aug 31, 2023
    • Interventions: Bupivacaine (Drug), Hydromorphone (Drug), Liposomal Bupivacaine (Drug), Questionnaires (Behavioral) to Bupivacaine (Drug), Fentanyl (Drug), Hydromorphone Hydrochloride (Drug), Implanted Medical Device (Device), Implanted Medical Device…
    • Eligibility criteria shortened, about 10 words
    • Secondary endpoints: 2 to 4
    • Study description shortened, about 736 words
    • Study site revised
    • Collaborators expanded, about 4 words
    • Study title expanded, about 1 word
  5. Site contact updatedv9
  6. Re-verified, no change to tracked fieldsv8
  7. Study description shortened, about 45 wordsv7
  8. 2 versions Re-verified since Nov 3, 2017, no change to tracked fieldsv5-v6
  9. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Dec 2022 to Oct 2022
    • Study completion date: Dec 2022 to Oct 2023
    • Start date changed from estimate of Dec 2017 to Oct 4, 2017
    • Site details revised
  10. Re-verified, no change to tracked fieldsv3
  11. Start date: Aug 2017 to Dec 2017
    • Primary and study completion dates: Aug 2022 to Dec 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This phase III trial studies how well thoracic epidural analgesia or four-quadrant transversus abdominus plane block works in reducing pain in patients undergoing liver surgery. It is not yet known whether thoracic epidural analgesia or four-quadrant transversus abdominus plane block may help people to recover more completely and more quickly after surgery.
Trial Details
NCT Number NCT03214510
Lead Sponsor M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Liver and Intrahepatic Bile Duct Disorder
Related terms Digestive System Diseases
Enrollment 101 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov